ProPhase Labs, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $1.2M | $784.0K | $883.0K | $1.2M | $1.4M | $1.5M | $1.4M |
| Cost of Revenue | $785.0K | $874.0K | $537.0K | $1.0M | $513.0K | $905.0K | $1.6M | $1.2M |
| Gross Profit | $226.0K | $295.0K | $247.0K | $-123.0K | $734.0K | $526.0K | $-150.0K | $215.0K |
| Gross Margin | 22.4% | 25.2% | 31.5% | -13.9% | 58.9% | 36.8% | -10.0% | 15.2% |
| Operating Expenses | ||||||||
| Research & Development | — | — | $0 | $6.0K | $4.0K | $97.0K | $60.0K | $122.0K |
| SG&A Expense | $2.9M | $2.7M | $6.0M | $4.6M | $4.6M | $4.1M | $17.1M | $6.6M |
| Operating Income | $-2.6M | $-2.4M | $-5.7M | $-4.8M | $-3.9M | $-3.7M | $-17.3M | $-6.5M |
| Operating Margin | -261.6% | -207.5% | -730.4% | -539.5% | -312.3% | -256.0% | -1,157.3% | -457.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-3.0M | $-3.8M | $-8.0M | $-7.0M | $-3.7M | $-4.7M | $-19.0M | $-7.5M |
| Income Tax Expense | $12.0K | $1.4M | $-622.0K | $-157.0K | $779.0K | $0 | $14.6M | $-2.5M |
| Net Income | $-3.1M | $-5.2M | $-7.4M | $-6.8M | $-4.5M | $4.0M | $-34.4M | $-6.6M |
| Net Margin | -301.8% | -442.7% | -943.6% | -774.5% | -358.6% | 277.1% | -2,299.8% | -465.2% |
| EPS (Basic) | $-0.22 | $-0.42 | $-1.63 | $-0.04 | $-0.27 | $0.28 | $-6.41 | $-0.09 |
| EPS (Diluted) | $-0.22 | $-0.42 | $-1.63 | $-0.04 | $-0.27 | $0.28 | $-6.41 | $-0.09 |
| Shares Outstanding (Basic) | 14.0M | 12.3M | 8.5M | 166.2M | 16.6M | 14.1M | 8.0M | 76.3M |
| Shares Outstanding (Diluted) | 14.0M | 12.3M | 8.5M | 166.2M | 16.6M | 14.1M | 8.0M | 76.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |